1. Home
  2. OBT vs LXEO Comparison

OBT vs LXEO Comparison

Compare OBT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$37.45

Market Cap

457.5M

Sector

Finance

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.64

Market Cap

387.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
LXEO
Founded
1892
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
457.5M
387.1M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
OBT
LXEO
Price
$37.45
$4.64
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$36.00
$18.44
AVG Volume (30 Days)
94.8K
928.6K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
2.12%
N/A
EPS Growth
34.82
39.81
EPS
0.85
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$14.27
N/A
Revenue Next Year
$7.99
N/A
P/E Ratio
$44.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.25
$3.60
52 Week High
$40.10
$10.99

Technical Indicators

Market Signals
Indicator
OBT
LXEO
Relative Strength Index (RSI) 65.16 46.90
Support Level $32.82 $4.44
Resistance Level $40.10 $5.34
Average True Range (ATR) 1.40 0.34
MACD 0.10 0.03
Stochastic Oscillator 49.17 42.48

Price Performance

Historical Comparison
OBT
LXEO

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: